The comparison of alternative treatments has long been a primary objective of researchers engaged in clinical investigation. However, with the commitment of $1.1 billion in support of clinical research in the American Recovery and Reinvestment Act,1 followed subsequently by the creation of the Patient Centered Outcomes Research Institute (PCORI) as part of the Affordable Care Act,2 “comparative...